Swittons Introduces IoT-Enabled Smart Devices for Pharmaceutical Labs
With the ability to be uniquely programmed, the devices provide user interfaces that can integrate with other systems and IoT devices, giving labs the ability to create their own Lab of the Future initiatives.
Swittons, a P360 company, introduced a new line of Internet of Things (IoT)-enabled smart devices for pharmaceutical labs. The devices work to automate laboratory workflows between people and existing digital lab equipment, systems, and solutions.
With the ability to be uniquely programmed, the devices provide user interfaces that can integrate with other systems and IoT devices, giving labs the ability to create their own Lab of the Future initiatives. Additionally, the new devices are compatible with laboratory information management systems, eDOC, and ticketing systems and feature a backend portal and reporting system.
“There are profound changes taking place in the area of life science research and development,” said Anupam Nandwana, Swittons’ CEO and founder, in an Aug. 11, 2020 company press release. “Driven by technological advances and the development of precision medicines, these modernization initiatives are designed to propel laboratory efficiencies into the future, allowing scientists to spend more time on science. This has changed the very concept of what the lab is, and Swittons is a key part of that evolution.”
Source: Swittons
Clinical Supply Planning in Europe - Balancing Cost, Flexibility and Time
December 19th 2024The packaging and distribution of clinical supplies is a fundamental piece to the overall success of a clinical trial, and advance preparation can help establish a more efficient supply chain. Selecting the best geographical location for those activities, however, depends on the clinical trial protocol, business decisions, and even the investigational medicinal product (IMP) being studied.
